Triglyceride-Rich Lipoprotein Metabolism: Key Regulators of Their Flux
Journal of Clinical Medicine · 29.06.2023 · 12 (13) · 4399
DOI: 10.3390/jcm12134399 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 29.06.2023. Verfasst von Alejandro Gugliucci. Beteiligte Einrichtung: Glycation, Oxidation and Disease Laboratory, Department of Research, Touro University California, Vallejo, CA 94592, USA. Die Arbeit wurde bisher 56-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The residual risk for arteriosclerotic cardiovascular disease after optimal statin treatment may amount to 50% and is the consequence of both immunological and lipid disturbances. Regarding the lipid disturbances, the role of triglyceride-rich lipoproteins (TRLs) and their remnants has come to the forefront in the past decade. Triglycerides (TGs) stand as markers of the remnants of the catabolism of TRLs that tend to contain twice as much cholesterol as compared to LDL. The accumulation of circulating TRLs and their partially lipolyzed derivatives, known as “remnants”, is caused mainly by ineffective triglyceride catabolism. These cholesterol-enriched remnant particles are hypothesized to contribute to atherogenesis. The aim of the present narrative review is to briefly summarize the main pathways of TRL metabolism, bringing to the forefront the newly discovered role of apolipoproteins, the key physiological function of lipoprotein lipase and its main regulators, the importance of the fluxes of these particles in the post-prandial period, their catabolic rates and the role of apo CIII and angiopoietin-like proteins in the partition of TRLs during the fast-fed cycle. Finally, we provide a succinct summary of the new and old therapeutic armamentarium and the outcomes of key current trials with a final outlook on the different methodological approaches to measuring TRL remnants, still in search of the gold standard.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Glycation, Oxidation and Disease Laboratory, Department of Research, Touro University California, Vallejo, CA 94592, USA.
ORCID-Profile: Alejandro Gugliucci
Zitieren
APA
Gugliucci, A. (2023). Triglyceride-Rich Lipoprotein Metabolism: Key Regulators of Their Flux. Journal of Clinical Medicine, 12(13), 4399. https://doi.org/10.3390/jcm12134399
Vancouver
Gugliucci A. Triglyceride-Rich Lipoprotein Metabolism: Key Regulators of Their Flux. Journal of Clinical Medicine. 2023;12(13):4399. doi:10.3390/jcm12134399
BibTeX
@article{Gugliucci2023,
author = {Gugliucci, Alejandro},
title = {Triglyceride-Rich Lipoprotein Metabolism: Key Regulators of Their Flux},
journal = {Journal of Clinical Medicine},
year = {2023},
volume = {12},
number = {13},
pages = {4399},
doi = {10.3390/jcm12134399}
}
EUVIMED